Circuit Clinical signs collaboration with cancer center

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Dmitrii_Guzhanin)
(Image: Getty/Dmitrii_Guzhanin)

Related tags: Circuit Clinical, Clinical trials

Circuit Clinical is providing digital and clinical services as part of its collaboration with a NY-based cancer center, patients at which will have expanded opportunities to participate in clinical trials.

The integrated research organization (IRO) Circuit Clinical will provide patient identification, engagement, enrollment, and other support services as part of its collaboration with the Roswell Park Comprehensive Cancer Center, a National Cancer Institute (NCI) designated cancer center in Upstate New York.

The collaboration marks Circuit Clinical’s entry into oncology clinical research as part of Roswell Park's CIMAvax Clinical Trial​ for certain forms of lung and head/neck cancer.

Thomas Schwaab, MD, PhD, Roswell Park's chief of strategy, business development and outreach, said in a statement: "We want to make sure that patients throughout our community who are eligible to participate in the CIMAvax Clinical Trial have a convenient opportunity to do so, whether they are getting their care at our main campus or one of our community practices."

In addition to its main campus in Buffalo, NY, Roswell Park will offer the trial at its satellite offices in Amherst and Niagara Falls as well as at its five affiliated community practices.

Also based in Buffalo, NY, Circuit Clinical recently partnered​ with the University at Buffalo’s (UB) genomics and biorepository program to add personalized medicine capabilities to its service offering lineup.

Circuit Clinical’s TrialScout platform – which rates and reviews clinical research sites – was developed in part with support from the University’s Center for Advanced Technology (UB CAT). UB awarded the company a $200,000 grant in late 2018.

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us


View more